comparison of two drugs for anaesthesia during dilation and curettage in females with abnormal menstrual bleeding
- Conditions
- Health Condition 1: N925- Other specified irregular menstruation
- Registration Number
- CTRI/2023/03/050236
- Lead Sponsor
- Ananta institute of medical sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Patients of abnormal uterine bleeding scheduled for elective endometrial sampling
American Society of Anaesthesiology I and II
History of cardiovascular diseases e.g. ischemic heart disease, conduction defects, etc.
History of compromised renal / hepatic / neuronal functions.
Uncontrolled Hypertension and Diabetes
History of alcohol, substance abuse, chronic use of analgesic and sedatives, psychiatric disorders
•Patients on beta blocker or having persistent bradycardia with HR <60.
•Drug allergy
•Procedure lasting for >30 min.
•Any surgical complications during D& C e.g. uterine perforation, excessive bleeding etc.
•Viable Pregnancy, acute PID, undiagnosed genital tract bleeding, mass in vagina or cervix, severe arthritis hip bone, bleeding disorders, virgin females
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Time to onset of sedation (Ramsay sedation score RSS 6) and recovery from sedation (RSS 3)Timepoint: Time to onset of sedation (Ramsay sedation score RSS 6) and recovery from sedation (RSS 3)
- Secondary Outcome Measures
Name Time Method 1.Intraoperative Haemodynamics (Heart Rate, Blood Pressure, Spo2, Respiratory rate) <br/ ><br>2.Post op recovery score ( Modified Aldrete Score) <br/ ><br>3.Duration of analgesia <br/ ><br>Timepoint: 0min, 10, 20, 30 min